Market revenue in 2023 | USD 408.4 million |
Market revenue in 2030 | USD 719.9 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.7% in 2023. Horizon Databook has segmented the U.S. clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share of the North America clinical trial imaging market. Some factors responsible for its dominance are aging demographic trends, advancing technologies, changing patient care strategies, and evolving epidemiological patterns.
In addition, government agencies in the U.S. pay for a large portion of clinical trials on treatments of cancer. The National Cancer Institute funds numerous clinical trials.
Cancer cooperative groups such as the National Surgical Adjuvant Breast & Bowel Project are networks of clinical centers and doctors in the U.S. that concentrate on a specific aspect or type of cancer. The cancer cooperative groups also pay for clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account